Artemisinin, a natural antimalarial product, suppresses uveal melanoma cell migration and invasion ability by inactivating PI3K/AKT/mTOR, which is reverted by AKT or mTOR activators such as Sc79 and MHY1485 [452]. Here, MTOR is linked to uveal melanoma.